A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

All GBS vaccine formulations induced a persistent antibody response and showed similar immunogenicity profiles (NCT01150123).